SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-025710
Filing Date
2019-07-24
Accepted
2019-07-24 08:01:36
Documents
55
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q odt-10q_20190630.htm 10-Q 977953
2 EX-31.1 odt-ex311_7.htm EX-31.1 18265
3 EX-31.2 odt-ex312_8.htm EX-31.2 18347
4 EX-32.1 odt-ex321_6.htm EX-32.1 15077
5 GRAPHIC gzfjznpnr1sv000001.jpg GRAPHIC 28085
  Complete submission text file 0001564590-19-025710.txt   3292038

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT odt-20190630.xml EX-101.INS 531905
7 XBRL TAXONOMY EXTENSION SCHEMA odt-20190630.xsd EX-101.SCH 31792
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE odt-20190630_cal.xml EX-101.CAL 30378
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE odt-20190630_def.xml EX-101.DEF 63384
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20190630_lab.xml EX-101.LAB 248088
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20190630_pre.xml EX-101.PRE 177724
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38318 | Film No.: 19969269
SIC: 2834 Pharmaceutical Preparations